Peptides / Retatrutide / Australia
Retatrutide in Australia
Legal status, what it is, and the listed suppliers in Australia that list it.
Legal status in Australia
Not an approved medicine. Not listed by name in the Poisons Standard (June 2026).
As understood at 2026-09-25. Verify with the TGA.
What Retatrutide is
Retatrutide is a synthetic peptide developed by Eli Lilly that acts on three hormone receptors at once: GLP-1, GIP and glucagon. It is an investigational drug in phase 3 clinical trials for obesity and type 2 diabetes and is not yet licensed anywhere. Its long duration of action comes from a fatty-acid chain attached to the peptide.
Listed suppliers in Australia
7 of the 10 suppliers we list in Australia list Retatrutide. Listed, not endorsed: each row is the supplier’s own stated terms.
Au Peptide Labs
Australia
For laboratory research use only. Not for human consumption.
Aussie Peptides
Australia
Research use only. Statements have not been evaluated by the TGA. We do not ship internationally at this time.
Australian Peptide Site
Australia
Intended for laboratory and scientific research use only.
Global Peptides
Australia
Unmodified peptides are sold for research use only.
Next Gen Peptides
Australia
Not for human consumption.
Peptide Solutions Australia
Australia
All products are supplied strictly for research purposes only. They are not intended for human consumption, animal consumption, medical use, diagnostic use, therapeutic use.
Synapse Peptides Australia
Australia
All products are supplied strictly for research purposes only and are not intended for human or veterinary use.